SOCS3 expression moderately detected in vivo in BCC and SCC lesions can be influenced by the complex tumor microenvironment, where other cytokines, such as IL-6, could induce SOCS3 via STAT3. The gene discussed is STAT3; the disease is skin basal cell carcinoma.